Go Pro
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Director Douglas Roeder Purchases 13,953 Shares

Senseonics Holdings, Inc. Common Stock logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Director Douglas Roeder purchased 13,953 SENS shares at an average price of $8.98, investing approximately $125,298 and increasing his direct ownership by 8.87% to 171,191 shares.
  • SENS shares fell 3.2% to $8.82 in mid-day trading, while the company’s latest quarterly loss of $0.63 per share missed analyst expectations of a $0.55 loss; revenue totaled $14.48 million.
  • Analyst sentiment remains a Moderate Buy, with four Buy, one Hold and one Sell rating and an average price target of $17.20, although several firms recently reduced their targets.
  • Five stocks to consider instead of Senseonics Holdings, Inc. Common Stock.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report) Director Douglas Roeder purchased 13,953 shares of the company's stock in a transaction on Wednesday, August 19th. The shares were purchased at an average cost of $8.98 per share, with a total value of $125,297.94. Following the transaction, the director directly owned 171,191 shares in the company, valued at $1,537,295.18. This trade represents a 8.87% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.

Senseonics Holdings, Inc. Common Stock Trading Down 3.2%

Shares of SENS stock traded down $0.29 during mid-day trading on Thursday, reaching $8.82. The stock had a trading volume of 523,538 shares, compared to its average volume of 667,163. The company has a 50-day moving average price of $6.06. Senseonics Holdings, Inc. Common Stock has a 52-week low of $4.79 and a 52-week high of $11.58. The company has a market capitalization of $368.68 million, a price-to-earnings ratio of -3.96 and a beta of 1.01. The company has a quick ratio of 6.40, a current ratio of 6.74 and a debt-to-equity ratio of 0.62.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported ($0.63) earnings per share for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.08). The firm had revenue of $14.48 million for the quarter. Senseonics Holdings, Inc. Common Stock had a negative return on equity of 165.80% and a negative net margin of 225.09%. On average, equities research analysts forecast that Senseonics Holdings, Inc. Common Stock will post -2.29 earnings per share for the current year.

Analyst Ratings Changes

SENS has been the topic of a number of recent analyst reports. Weiss Ratings lowered Senseonics Holdings, Inc. Common Stock from a "sell (d-)" rating to a "sell (e+)" rating in a research report on Wednesday, August 12th. Mizuho decreased their target price on Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an "outperform" rating for the company in a report on Wednesday, July 15th. Wall Street Zen raised Senseonics Holdings, Inc. Common Stock from a "strong sell" rating to a "sell" rating in a research note on Saturday, August 8th. HC Wainwright cut their price target on shares of Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a "buy" rating on the stock in a report on Tuesday, May 12th. Finally, Stifel Nicolaus reduced their price objective on shares of Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a "hold" rating on the stock in a research report on Monday, May 11th. Four equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $17.20.

Read Our Latest Analysis on Senseonics Holdings, Inc. Common Stock

Institutional Trading of Senseonics Holdings, Inc. Common Stock

Several large investors have recently bought and sold shares of the company. Goldman Sachs Group Inc. grew its holdings in shares of Senseonics Holdings, Inc. Common Stock by 26.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 612,534 shares of the company's stock worth $402,000 after acquiring an additional 127,086 shares during the period. Geode Capital Management LLC lifted its stake in shares of Senseonics Holdings, Inc. Common Stock by 26.6% in the 2nd quarter. Geode Capital Management LLC now owns 8,701,129 shares of the company's stock valued at $4,147,000 after purchasing an additional 1,828,302 shares during the period. Walleye Capital LLC purchased a new position in shares of Senseonics Holdings, Inc. Common Stock in the 2nd quarter valued at approximately $539,000. Sei Investments Co. bought a new stake in shares of Senseonics Holdings, Inc. Common Stock during the second quarter valued at approximately $761,000. Finally, First Light Asset Management LLC boosted its position in shares of Senseonics Holdings, Inc. Common Stock by 666.7% during the second quarter. First Light Asset Management LLC now owns 35,708,124 shares of the company's stock valued at $17,011,000 after purchasing an additional 31,050,619 shares in the last quarter. 12.36% of the stock is owned by institutional investors.

Senseonics Holdings, Inc. Common Stock Company Profile

(Get Free Report)

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Senseonics Holdings, Inc. Common Stock Right Now?

Before you consider Senseonics Holdings, Inc. Common Stock, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Senseonics Holdings, Inc. Common Stock wasn't on the list.

While Senseonics Holdings, Inc. Common Stock currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines